XENON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Xenon, and what generic alternatives are available?
Xenon is a drug marketed by Mallinckrodt, Curium, Ge Healthcare, Gen Electric, Shine, and Lantheus Medcl. and is included in seven NDAs.
The generic ingredient in XENON is xenon xe-133. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the xenon xe-133 profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for XENON?
- What are the global sales for XENON?
- What is Average Wholesale Price for XENON?
Summary for XENON
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 7 |
| Drug Prices: | Drug price information for XENON |
| What excipients (inactive ingredients) are in XENON? | XENON excipients list |
| DailyMed Link: | XENON at DailyMed |
US Patents and Regulatory Information for XENON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt | XENON XE 127 | xenon xe-127 | GAS;INHALATION | 018536-001 | Oct 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ge Healthcare | XENON XE 133 | xenon xe-133 | GAS;INHALATION | 017687-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Curium | XENON XE 133 | xenon xe-133 | GAS;INHALATION | 018327-002 | Mar 9, 1982 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ge Healthcare | XENON XE 133 | xenon xe-133 | INJECTABLE;INJECTION | 017256-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Gen Electric | XENON XE 133 | xenon xe-133 | GAS;INHALATION | 017550-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
